Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Registration


The cost for this online course is $15. The estimated time to complete this course is 45 minutes. Learners will be asked to complete an activity post-assessment with a passing score of 75%.

You must log in or create an account before enrolling in this educational activity. 

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage.
 

Target Audience

Healthcare professionals.

Educational Need

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, impulsivity, and hyperactivity that interfere with daily functioning and development. It commonly manifests in childhood but can persist into adolescence and adulthood. ADHD can significantly impact academic performance, social interactions, and emotional well-being if left untreated. 

Recent statistics on ADHD prevalence globally vary, but according to the Centers for Disease Control and Prevention (CDC) in the United States:

  • As of 2021, approximately 9.4% of children aged 2-17 years had received an ADHD diagnosis.
  • Boys are diagnosed with ADHD more frequently than girls.
  • The prevalence of ADHD can vary among different age groups and demographics.
  • Diagnosis rates have been rising steadily, which could be due to increased awareness, better identification, and changing diagnostic criteria.

Objectives

  1. Define Attention Deficit Hyperactivity Disorder (ADHD) and DSM criteria for diagnosis.
  2. Identify multiple non-pharmacological treatment options for ADHD.
  3. Identify multiple pharmacologic treatment options for ADHD.

Speakers

Sean Barrett, DO
Broadlawns UnityPoint Psychiatry Residency Program

Biography

Lori Suvalsky, MD
Site Director, VA Central Iowa Health Care

Biography


Terms of Use and Privacy Policy

Recording date: October 27, 2023
Date of original release: October 28, 2023
Most recent review/update: October 28, 2023
Termination date: October 27, 2025

Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credits
  • 0.75 AOA Category 1­B
  • 0.75 CE Contact Hour(s)
  • 0.75 CPME
Course opens: 
10/28/2023
Course expires: 
10/27/2026
Cost:
$15.00

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.75 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this activity for a maximum of 0.75 continuing education contact hours.
  • Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 

DISCLOSURE

The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individuals do not have a financial relationship with an ineligible company; however, they intend to discuss the off-label use of a commercial product or device. They agree to inform the learners before their presentation. 

  • Sean Barrett, DO - Speaker
  • Lori Suvalsky, MD - Speaker

Disclaimer

The information provided in this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 0.75 AMA PRA Category 1 Credits
  • 0.75 AOA Category 1­B
  • 0.75 CE Contact Hour(s)
  • 0.75 CPME

Price

Cost:
$15.00
Please login or Create an Account to take this course.